Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MNOV [NASD]
MediciNova Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own3.20% Shs Outstand17.28M Perf Week32.16%
Market Cap58.22M Forward P/E- EPS next Y- Insider Trans40.38% Shs Float20.42M Perf Month-1.46%
Income-11.00M PEG- EPS next Q-0.11 Inst Own8.70% Short Float1.08% Perf Quarter13.85%
Sales0.80M P/S72.77 EPS this Y45.00% Inst Trans6.75% Short Ratio2.58 Perf Half Y97.08%
Book/sh0.86 P/B3.92 EPS next Y- ROA-48.40% Target Price6.00 Perf Year105.49%
Cash/sh0.23 P/C14.55 EPS next 5Y20.00% ROE-62.80% 52W Range1.49 - 4.70 Perf YTD105.49%
Dividend- P/FCF- EPS past 5Y30.80% ROI-73.20% 52W High-28.30% Beta0.99
Dividend %- Quick Ratio4.40 Sales past 5Y- Gross Margin- 52W Low126.17% ATR0.31
Employees12 Current Ratio4.40 Sales Q/Q-98.30% Oper. Margin- RSI (14)59.34 Volatility14.13% 7.47%
OptionableNo Debt/Eq0.00 EPS Q/Q36.40% Profit Margin- Rel Volume11.38 Prev Close2.57
ShortableYes LT Debt/Eq0.00 EarningsNov 13 Payout- Avg Volume85.29K Price3.37
Recom1.00 SMA2016.93% SMA5010.78% SMA20047.72% Volume832,900 Change31.13%
04-Jan-13Reiterated Ladenburg Thalmann Buy $10.50 → $6
24-May-12Downgrade MLV & Co Buy → Hold
18-Oct-11Reiterated MLV Capital Buy $13 → $6
22-Jun-11Initiated Global Hunter Securities Buy $4
12-May-10Initiated Wedbush Outperform $13
12-Nov-08Reiterated Ladenburg Thalmann Buy $22 → $6
15-May-08Initiated Rodman & Renshaw Mkt Outperform $9
09-Jul-07Initiated Punk, Ziegel & Co Buy $22
19-Jun-13 06:05PM  Nasdaq stocks posting largest volume increases AP +31.13%
05:15PM  MediciNova Presents MN-166 Data Zacks
18-Jun-13 06:04PM  InPlay: MediciNova: UCLA presents data on MediciNova's MN-166 in methamphetamine addicition Briefing.com
06:00PM  UCLA Presents Data on MediciNova's MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of the College on Problems of Drug Dependence GlobeNewswire
17-Jun-13 07:32AM  MEDICINOVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu EDGAR Online
07-Jun-13 10:21AM  MEDICINOVA INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr EDGAR Online
14-May-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials -6.10%
13-May-13 01:34PM  Monday Sector Leaders: Biotechnology, Drugs at Forbes +16.48%
09-May-13 11:13PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities EDGAR Online -26.78%
02:01AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-May-13 05:30PM  MediciNova Reports First Quarter 2013 Results GlobeNewswire +10.50%
10:10AM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
18-Apr-13 06:35AM  MedicNova enters into 6M equity distribution agreement with Macquarie at theflyonthewall.com +6.72%
17-Apr-13 11:19PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
09:08AM  MEDICINOVA INC Files SEC form 8-K, Other Events EDGAR Online
03-Apr-13 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
29-Mar-13 02:02AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
28-Mar-13 05:30PM  MediciNova Reports Fourth Quarter and Full Year 2012 Results GlobeNewswire
10:16AM  MEDICINOVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
10:08AM  MEDICINOVA INC Files SEC form 10-K, Annual Report EDGAR Online
21-Mar-13 01:23AM  InPlay: MediciNova presents data from MN-166 opioid withdrawal and analgesia data Briefing.com
20-Mar-13 07:00PM  MediciNova Announces MN-166 (ibudilast) Opioid Withdrawal and Analgesia Data Presentation at the American Academy of Neurology Annual Meeting GlobeNewswire +5.71%
03-Mar-13 08:32AM  5 of Last Week's Biggest Winners at Motley Fool
01-Mar-13 05:02PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -12.35%
28-Feb-13 03:24PM  Thursdays movers: Herbalife gets more Icahn lift at MarketWatch +7.59%
01:45PM  Thursdays movers: Sears covered in red ink at MarketWatch
11:18AM  Thursdays movers: J.C. Penney is S&P 500 laggard at MarketWatch
10:27AM  Thursdays movers: Groupon sinks on surprise loss at MarketWatch
09:09AM  Thursdays biggest gaining and declining stocks at MarketWatch
27-Feb-13 06:02PM  Nasdaq stocks posting largest volume increases AP +6.04%
01:49PM  Secretive Dilution And A Possible Equity Financing From MediciNova at Seeking Alpha
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwired
08:20AM  Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire
26-Feb-13 06:15PM  Nasdaq stocks posting largest volume increases AP +39.25%
05:54PM  4 Healthcare Stock Stories to Heal the Tuesday Blues at Wall St. Cheat Sheet
25-Feb-13 06:01PM  InPlay: MediciNova: FDA grants Fast Track designation for MediciNova's MN-166 (ibudilast) for the treatment of methamphetamine dependence Briefing.com +5.42%
06:00PM  FDA Grants Fast Track Designation for MediciNova's MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence GlobeNewswire
03-Jan-13 06:00PM  MediciNova Provides Development Update GlobeNewswire
09-Dec-12 06:30PM  MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma GlobeNewswire
20-Nov-12 06:01PM  InPlay: MediciNova announces initiation of a clinical trial of MN-166 in opioid abusers Briefing.com
06:00PM  MediciNova Announces Initiation of a Clinical Trial of MN-166 in Opioid Abusers With Columbia University and the New York State Psychiatric Institute GlobeNewswire
18-Nov-12 06:00PM  MediciNova Extends MN-166 Patent Position in Europe GlobeNewswire
16-Nov-12 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials -10.11%
14-Nov-12 06:00PM  MediciNova to Present at the Fourth World Congress of Emergency Medicine GlobeNewswire -5.10%
12-Nov-12 06:05PM  MedicNova announces publication of positive phase 2 clinical results theflyonthewall.com
06:00PM  MediciNova Announces Publication of MN-221 Clinical Results in Journal of Asthma GlobeNewswire
09-Nov-12 09:02AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
08-Nov-12 06:00PM  MediciNova Reports Third Quarter 2012 Results and Update on MN-221 Development GlobeNewswire
05:15PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
07-Nov-12 06:00PM  MediciNova to Present at the Lazard Capital Markets Healthcare Conference GlobeNewswire
25-Oct-12 07:01PM  InPlay: MediciNova receives a notice of European patent allowance for treating progressive multiple sclerosis Briefing.com
07:00PM  MediciNova Receives a Notice of European Patent Allowance for Treating Progressive Multiple Sclerosis GlobeNewswire
22-Oct-12 07:01PM  InPlay: MediciNova meets with FDA for end-of-Phase 2 meeting for MN-221 for the treatment of acute exacerbations of asthma Briefing.com
07:00PM  MediciNova Meets With FDA for End-of-Phase 2 Meeting for MN-221 for the Treatment of Acute Exacerbations of Asthma GlobeNewswire
05-Sep-12 07:17AM  InPlay: MediciNova, UCLA and the Jasdaq Market announce that funds UCLA Phase 2 study of MediciNova's MN-166 in treating drug addiction Briefing.com
04-Sep-12 07:00PM  NIH Funds UCLA Phase 2 Study of MediciNova's MN-166 in Treating Drug Addiction GlobeNewswire
28-Aug-12 07:00PM  MediciNova to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11, 2012 GlobeNewswire
24-Aug-12 04:59PM  Positive Data on MediciNova's MN-221 Zacks
01:03AM  InPlay: MediciNova provides positive preliminary results from a multi-day, repeat-dose clinical trial with MN-221 in chronic obstructive pulmonary disease patients Briefing.com
23-Aug-12 07:00PM  MediciNova Announces Positive Preliminary Results From a Multi-Day, Repeat-Dose Clinical Trial With MN-221 in Chronic Obstructive Pulmonary Disease Patients GlobeNewswire
22-Aug-12 05:21PM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities EDGAR Online
21-Aug-12 06:09AM  MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online
12:49AM  InPlay: MediciNova enters into a $20 mln common stock purchase agreement with Aspire Capital Fund Briefing.com
20-Aug-12 07:00PM  MediciNova Enters Into a $20 Million Common Stock Purchase Agreement With Aspire Capital Fund GlobeNewswire
17-Aug-12 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
10-Aug-12 05:22PM  3 Reasons This Speculative Bio-Pharma Is A Winner at Seeking Alpha
06:05AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09-Aug-12 07:00PM  MediciNova Reports Second Quarter 2012 Results GlobeNewswire
05:15PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05-Jul-12 09:32AM  MEDICINOVA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.80%
03-Jul-12 06:36AM  InPlay: MediciNova announced earlier scheduling of End-of-Phase 2 meeting with FDA for MN-221 for the treatment of acute exacerbations of asthma Briefing.com +25.00%
02-Jul-12 07:21PM  MedicNova announces scheduling of End-of-Phase 2 meeting with FDA theflyonthewall.com
07:00PM  MediciNova Announces Scheduling of End-of-Phase 2 Meeting With FDA for MN-221 for the Treatment of Acute Exacerbations of Asthma GlobeNewswire
06:30PM  MediciNova to Present at the JMP Securities Seventh Annual Healthcare Conference GlobeNewswire
18-Jun-12 05:02PM  MEDICINOVA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
25-May-12 06:09PM  Nasdaq stocks posting largest volume increases AP +11.46%
24-May-12 06:06PM  Nasdaq stocks posting largest volume increases AP -42.91%
02:50PM  Must Know Stock Upgrades and Downgrades Today at Wall St. Cheat Sheet
12:49PM  Signet Jewelers, MediciNova: Biggest Price Decliners (SIG, MNOV) at The Wall Street Journal
12:46PM  MediciNova dives on asthma study results at MarketWatch
10:08AM  MediciNova asthma drug fails trial; shares crash at Reuters
10:08AM  MediciNova asthma drug fails trial; shares crash Reuters
09:14AM  Stocks to Watch: Hewlett-Packard, Pandora, Tiffany at The Wall Street Journal
04:44AM  MediciNova downgraded by MLV & Co Briefing.com
23-May-12 06:49PM  H-P climbs, NetApp tumbles in after-hours trade at MarketWatch -5.50%
06:01PM  MediciNova asthma drug fails trial; shares crash at Reuters
06:00PM  MediciNova asthma drug fails trial; shares crash Reuters
05:00PM  MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma Exacerbations - Call scheduled for 5:00 pm ET today CCBN
04:00PM  InPlay: MediciNova reports results of a Phase 2b clinical trial of MN-221 in asthma exacerbations says 'there was a significant improvement in clinical symptoms with MN-221 treated patients and the safety profile' Briefing.com
04:00PM  MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma Exacerbations GlobeNewswire
18-May-12 01:04PM  MEDICINOVA INC Financials EDGAR Online Financials
17-May-12 01:05PM  MEDICINOVA INC Financials EDGAR Online Financials +5.56%
11-May-12 01:20PM  [video] Friday Sector Leaders: General Contractors & Builders, Biotechnology Stocks at Forbes
12:35PM  Friday Sector Leaders: General Contractors & Builders, Biotechnology Stocks at Forbes
06:09AM  MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
10-May-12 05:43PM  InPlay: MediciNova reports a Q1 loss of ($0.24) vs a loss of ($0.45) in last year's quarter; revs were reported as $191,174 Briefing.com +9.03%
05:30PM  MediciNova Reports First Quarter 2012 Results GlobeNewswire
05:04PM  MEDICINOVA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
08-May-12 06:15PM  Nasdaq stocks posting largest volume increases AP
07-May-12 06:15PM  Nasdaq stocks posting largest volume increases AP +5.63%
MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a 2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.